Latest filing published 16 Mar 2020 for Enliven Therapeutics, Inc..
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Barbara Dalton: trading record in brief
This profile gathers the share dealings of Barbara Dalton in Enliven Therapeutics, Inc. Altogether 2 filings, all relating to 16 March 2020.
No open-market sale appears; the market trades are 1 purchase worth €4.5M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
Most recently, on 16 March 2020, the filings show a transaction in Enliven Therapeutics, Inc. The most recent open-market purchase was published on 16 March 2020, 2,429 days ago. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Barbara Dalton
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,245,222 sharesCommon StockSEC:0000899243-20-008496:0
- 312,500 shares@ US$16.00100.0% of flowCommon StockSEC:0000899243-20-008496:1Canonical exit: 14 Jun 2020 (T+90)
2 of 1 declaration
